Article Text

other Versions

Endothelial protein C receptor is over-expressed in rheumatoid arthritic (RA) synovium and mediates the anti-inflammatory effects of activated protein C in RA monocytes
  1. Meilang Xue (mlxue{at}
  1. The University of Sydney, Australia
    1. Lyn March (lynmar{at}
    1. The University of Sydney, Australia
      1. Philip N Sambrook (sambrook{at}
      1. The University of Sydney, Australia
        1. Fenji Fukudome (fukudome{at}
        1. Saga Medical School, Japan
          1. Christopher J Jackson (cjackson{at}
          1. The University of Sydney, Australia


            Objectives: i) To investigate whether inflammatory synovial tissues from patients with rheumatoid arthritis (RA) express endothelial protein C receptor (EPCR) and ii) to determine the major cell type (s) that EPCR is associated with and whether EPCR functions to mediate the effects of activated protein C (APC) on these cells.

            Methods: EPCR, CD68 and PC/APC in synovial tissues were detected by immunostaining and in situ PCR. Monocytes were isolated from peripheral blood of patients with RA and treated with APC, lipopolysaccharide (LPS), and/or EPCR blocking antibody RCR252. Cells and supernatants were collected for RT-PCR, western blotting, enzyme-linked immuosorbent assay and chemotaxis assay.

            Results: EPCR was expressed by both OA and RA synovial tissues but was markedly increased in RA synovium. EPCR was colocalized with PC/APC mostly on CD68 positive cells in synovium. In RA monocytes, APC upregulated EPCR expression and reduced monocyte chemoattractant protein-1-induced chemotaxis of monocytes by approximately 50%. APC also completely suppressed LPS-stimulated NF-κB activation and attenuated TNF-α protein by more than 40% in RA monocytes. The inhibitory effects of APC were reversed by RCR252, indicating that EPCR is required.

            Conclusions: Our results demonstrate for the first time that EPCR is expressed by synovial tissues, particularly in RA, where it co-localizes with PC/APC on monocytes/macrophages. In addition, APC inhibits the migration and activation of RA monocytes via EPCR. These inhibitory effects on RA monocytes suggest that PC pathway may have a beneficial therapeutic effect in RA.

            • activated protein C
            • endothelial protein C receptor
            • migration and activation
            • monocytes
            • rheumatoid arthritis

            Statistics from

            Request Permissions

            If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.